Haemonetics to Present at Morgan Stanley’s Global Healthcare Conference on September 13, 2018

Haemonetics Corporation announced that Chris Simon, President and CEO, will present at Morgan Stanley’s Global Healthcare Conference in New York on Thursday, September 13, 2018 at 11:10am Eastern time.

BRAINTREE, Mass., Aug. 30, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley’s Global Healthcare Conference in New York on Thursday, September 13, 2018 at 11:10am Eastern time.

The public may access Mr. Simon’s presentation live via webcast and subsequent replay at: https://cc.talkpoint.com/morg007/091218a_as/?entity=117_5KF5F3F.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit http://www.haemonetics.com.

CONTACT
Gerry Gould, VP-Investor Relations
(781) 356-9402
gerry.gould@haemonetics.com

View original content with multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-morgan-stanleys-global-healthcare-conference-300704493.html

SOURCE Haemonetics Corporation

Company Codes: NYSE:HAE

MORE ON THIS TOPIC